Droplet microarray platforms for high-throughput drug screening

High-throughput screening platforms are fundamental for the rapid and efficient processing of large amounts of experimental data. Parallelization and miniaturization of experiments are important for improving their cost-effectiveness. The development of miniaturized high-throughput screening platfor...

Full description

Saved in:
Bibliographic Details
Published inMikrochimica acta (1966) Vol. 190; no. 7; p. 260
Main Authors Shi, Lina, Liu, Sutong, Li, Xue, Huang, Xiwei, Luo, Hongzhi, Bai, Qianwen, Li, Zhu, Wang, Lijun, Du, Xiaoxin, Jiang, Cheng, Liu, Shan, Li, Chenzhong
Format Journal Article
LanguageEnglish
Published Vienna Springer Vienna 01.07.2023
Springer
Springer Nature B.V
Subjects
Analytical Chemistry
Characterization and Evaluation of Materials
Chemistry
Chemistry and Materials Science
Droplets
Drug Evaluation, Preclinical
High-Throughput Screening Assays - methods
Microarray Analysis - methods
Microengineering
Nanochemistry
Nanotechnology
Nucleic acids
Pharmacology
Platforms
Reagents
Review Article
Screening
High-throughput screening
Droplet microarray
Superhydrophobic–superhydrophilic pattern
Surface chemistry
Online AccessGet full text

Cover

More Information
Summary:High-throughput screening platforms are fundamental for the rapid and efficient processing of large amounts of experimental data. Parallelization and miniaturization of experiments are important for improving their cost-effectiveness. The development of miniaturized high-throughput screening platforms is essential in the fields of biotechnology, medicine, and pharmacology. Currently, most laboratories use 96- or 384-well microtiter plates for screening; however, they have disadvantages, such as high reagent and cell consumption, low throughput, and inability to avoid cross-contamination, which need to be further optimized. Droplet microarrays, as novel screening platforms, can effectively avoid these shortcomings. Here, the preparation method of the droplet microarray, method of adding compounds in parallel, and means to read the results are briefly described. Next, the latest research on droplet microarray platforms in biomedicine is presented, including their application in high-throughput culture, cell screening, high-throughput nucleic acid screening, drug development, and individualized medicine. Finally, the challenges and future trends in droplet microarray technology are summarized. Graphical Abstract
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0026-3672
1436-5073
DOI:10.1007/s00604-023-05833-9